VANI Vivani Medical Inc.
Company Analysis
Latest News
🔴 Vivani Medical is trading 6% down today as major indexes fall
Vivani Medical is trading 6.03% lower at $1.09 on October 22, 2026, with broader market weakness the most plausible context. - Reports linked market weakness...
🔴 Vivani Medical is trading 5.5% down on October 8, 2026 amid biotech and market weakness
Vivani Medical is trading at $1.20, down 5.51%, amid sector and broader market pressure; no company-specific catalyst was identified. - The latest listed...
🟢 Vivani Medical is trading 5% up with no clear catalyst identified
Vivani Medical is trading at $1.30, up 5.03%, with no clear catalyst identified. - No new company-specific announcement was identified for October 7; Vivani...
🟢 Vivani Medical is trading 10% up in pre-market
Vivani Medical is trading at $1.34, up 9.84% in pre-market, with no fresh company-specific announcement identified to explain the October 6 move. - The latest...
🟢 Vivani Medical is trading 5% up today as broader risk-on sentiment lifted U.S. equities
Vivani Medical is trading 5% up at $1.25 as broader risk-on sentiment lifted U.S. equities on September 21, 2026. - Falling oil prices and easing Treasury...
Vivani Expects Cortigent and ClearOne Merger to Close in October 2026
Vivani Medical, Inc. provided a timeline update for the previously announced merger involving its wholly owned subsidiary, Cortigent, Inc. The company...
Vivani Medical Eyes November Data, Advancing Twice-Yearly Obesity Implant
Vivani Medical presented its obesity implant technology at the H.C. Wainwright 28th Annual Global Investment Conference on September 11, 2026. The proposed...
🟢 Vivani Medical is trading 7.2% up in pre-market amid broader risk-on sentiment
Vivani Medical is trading at $1.34, 7.20% up, on September 11, 2026, amid firmer pre-market indices and broader risk-on sentiment. - A pre-recorded H.C....
🟢 Vivani Medical is trading 5.54% up in pre-market with no clear company-specific catalyst identified
Vivani Medical is trading at $1.43 (+5.54%) after no clear company-specific catalyst was identified for September 9, 2026. • The latest company announcement...
🔴 Vivani Medical is trading 6% down today — reason remains unclear
Vivani Medical is trading 6% down now at $1.40, with the specific reason for the decline unclear. - No clear company-specific announcement or catalyst dated...
🟢 Vivani Medical is trading 6.5% up — catalyst unidentified
Vivani Medical is trading 6.5% up at $1.48; the specific catalyst remains unidentified. - Its latest announcement, issued September 3, 2026, concerned...
🟢 Vivani Medical is trading 5% up today amid biotech strength
Vivani Medical is trading 5.15% higher at $1.43, mainly in line with biotech strength as XBI rises 2.75%. - No new company-specific announcement was...
🔴 Vivani Medical is trading 5% down today with no confirmed catalyst identified
Vivani Medical is trading 5.17% down at $1.38, with no confirmed catalyst identified. - No new company-specific announcement dated August 19, 2026, was...
🟢 Vivani Medical is trading 5% up today; no clear catalyst identified
Vivani Medical is trading 5% up at $1.42, based on live price context for August 18, 2026; the stock-specific gain remains unexplained. - No major...
🟢 Vivani Medical is trading 5.38% up in pre-market after narrower Q2 loss
Vivani Medical is trading 5.38% up in pre-market at $1.41 after August 13, 2026, second-quarter results showed a narrower $6.4 million net loss and quarterly...
Vivani Medical narrows second quarter 2026 loss to $6.4M as NPM-139 clinical trial dosing completes
Vivani Medical reported a net loss of $6.4 million for the second quarter of 2026, a slight improvement from the $7.1 million loss in the same period last...
🔴 Vivani Medical is trading 5.7% down in pre-market — no clear company-specific catalyst identified
Vivani Medical is trading 5.7% down at $1.33 in pre-market after closing at $1.41 on August 10, 2026; no clear company-specific catalyst was identified for the...
Vivani Medical Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
Analysts expect Vivani Medical to report a loss of $0.08 per share on zero revenue for Q2 2026, with the stock currently trading near $1.40 against a consensus...
🟢 Vivani Medical is trading 5% up today after completing dosing for all 20 SLIM-1 participants
Vivani Medical is trading 5.15% up now at $1.43 after announcing on August 6, 2026, that all 20 participants had been dosed in its SLIM-1 Phase 1 trial of...
Vivani Medical Completes Participant Dosing in Phase 1 Trial for Semaglutide Implant
Vivani Medical announced it has successfully completed the initial dosing of all 20 participants in its SLIM-1 Phase 1 clinical trial. The trial is evaluating...